Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > trying to understand?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(559)
•••
Comment by chrispion Apr 22, 2022 12:40pm
125 Views
Post# 34624209

RE:RE:RE:RE:RE:trying to understand?

RE:RE:RE:RE:RE:trying to understand?The price of food is an important one. Most of the world lives paycheck to paycheck. With the price of oil, food, and other commodities spiking, etc., there's talk of food riots, etc. The world needs more of the basics immediately and not speculative science that may take a decade to develop. First we got to eat, etc.

Poof, is this post doesn't show how "flippy" you are (going positive, then negative, then rinse & repeat) then people are crazy. What does this have to do with Bioasis except for you stirring up FUD? Why did you not mention WW3 could be happening when the Ukraine war started about 6 weeks ago? What about the supply chain issues affecting the world. Geez, you really are a "do the opposite for what I say" type of investor trying to mislead investors for your own gain.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities